ERF.PA

EUROFINS SCIENT.
ParisEUREQUITY Healthcare DELAYED
Last price
72.50
▼ 0.32 (0.44%)
MARKET ·

Price

Open
72.18
Prev close
72.82
Day high
72.84
Day low
71.84
Volume
210.86K
Market cap
$12.56B
P/E (TTM)
25.29
52W range
54.86 – 74.32

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
63.37M
Total on file

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 72.50
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+3.41% +4.8%
1M
+10.16% +6.4%
3M
+17.56% +14.5%
6M
+9.83% -1.2%
YTD
+16.73% +4.4%
1Y
+11.14% -8.9%
3Y
+28.19% -46.0%
5Y
-41.51%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$12.56B
Enterprise value$16.53B
Revenue (TTM)$7.39B
Gross profit$1.71B
EBITDA$1.54B
Net income$469.90M
EPS (TTM)$2.88
Free cash flow$339.56M
Total cash$617.80M
Total debt$4.47B
Book value / share$20.85
Shares outstanding172.37M
Float110.07M
Short % of float
Dividend yield0.99%
Beta (5Y)0.84

Valuation & profitability ratios

Account required
Trailing P/E25.29
Forward P/E15.50
PEG ratio1.07
Price / sales
Price / book3.49
EV / revenue2.24
EV / EBITDA10.75
Gross margin23.13%
Operating margin16.17%
Profit margin7.17%
Return on equity11.33%
Return on assets5.99%
Debt / equity96.12
Current ratio1.13
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 3 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $7.30B$6.95B$6.51B$6.71B +5.0%
Operating revenue $7.30B$6.95B$6.51B$6.71B +5.0%
Cost of revenue $2.33B$2.24B$2.15B$2.23B +3.9%
Gross profit $4.97B$4.71B$4.36B$4.49B +5.5%
Total operating expense $4.15B$3.99B$3.82B$3.70B +4.2%
Operating income $818.30M$726.20M$546.80M$783.20M +12.7%
Net interest income -$146.50M-$131.50M-$117.80M-$103.90M -11.4%
Pre-tax income $654.10M$554.60M$423.30M$780.00M +17.9%
Tax provision $181.10M$149.10M$115.50M$174.20M +21.5%
Net income $474.80M$406.40M$310.20M$610.20M +16.8%
Net income to common $474.80M$406.40M$310.20M$610.20M +16.8%
Basic EPS 2.642.131.613.17 +23.9%
Diluted EPS 2.552.091.573.07 +22.0%
EBIT $811.20M$705.40M$552.70M$885.60M +15.0%
EBITDA $1.53B$1.40B$1.22B$1.49B +9.8%
Basic shares 179.80M190.60M192.90M192.50M -5.7%
Diluted shares 186.50M194.50M197.90M199.00M -4.1%

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year 4.14 11 $7.59B +4.0%
Next year 4.70 12 $8.01B +5.6%

Analyst targets & ownership

Account required
Mean target$72.53
High target$86.00
Low target$58.00
Implied upside0.04%
Analyst count14
ConsensusBUY
Strong buy / Buy2 / 4
Hold6
Sell / Strong sell1 / 1
Held by insiders36.50%
Held by institutions34.22%
Institutions holding355
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
70.61
+2.68% from price
SMA 20
69.64
+4.59% from price
SMA 50
68.35
+6.57% from price
SMA 100
65.63
+10.47% from price
SMA 200
64.72
+12.54% from price
EMA 12
70.66
+2.61% from price
EMA 26
69.68
+4.05% from price
EMA 50
68.39
+6.01% from price
RSI (14)
68.7
Neutral
MACD (12,26,9)
0.98
Hist 0.25
ATR (14)
1.18
1.62% of price
Realised vol 30D
25.2%
Annualised
Bollinger upper
72.47
20, 2σ
Bollinger lower
66.82
20, 2σ
50 / 200 cross
Golden
68.35 vs 64.72
Trend bias
Above 200
+12.54%

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.08
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
25.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-21.3%
Peak to trough
Max drawdown 5Y
-65.0%
Peak to trough
ATR 14
1.18
1.62% of price
Beta (reported)
0.84
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate$0.72 / yr
Forward yield0.99%
5-year avg yield1.22%
Payout ratio25.00%
Ex-dividend dateApr 28, 2026
Next pay date
Last split10:1
Split dateNov 19, 2020

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.